MYGN Supreme Court Ruling a Positive for Gene Testing Firms
Very positive development enabling gene testing companies to continue to develop genetic tests....that's a big positive for CLRX, given the plethora of tests and drugs that will be created going forward. I will continue to pound the table that the information that is being created is going to overwhelm physicians. To have a database to turn to for information on testing, drug, and clinical trial options for next steps to take is invaluable. All genetic testing companies will want physicians to know what to do based on the results of their tests...there will be thousands of tests created going forward. Provided it executes, CLRX is extremely well positioned to provide tremendous benefit at the point of care. When LIFE Technologies sees that, and other firms are starting to see it to, you can be sure that additional deals are possible with firms like MYGN, GHDX, ILMN, SQNM, NSPH, RGDX, ROSG, RHHBY, etc., etc., etc.
Listened to a podcast on NPR this week on exactly this subject. They stated emphatically that most physicians have little or no genetics training. As the demand by the public for personal genome testing grows exponentially physicians will need the kind of tools CLRX provides in order to stay in the game.